Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP12 Fenbendazole: A Dewormer's Journey to Cancer-Fighting Potential
Fenben® Voices
4 minutes
1 year ago
S1EP12 Fenbendazole: A Dewormer's Journey to Cancer-Fighting Potential
Got Questions? Send us a message!Join us on this episode of "Fenben Voices" for a deep dive into "Fenbendazole: A Dewormer's Journey to Cancer-Fighting Potential." We explore the surprising emergence of fenbendazole, a drug known for its veterinary applications, as a potential player in the fight against cancer. This episode peels back the layers of scientific research, anecdotal evidence, and the ongoing debate within the medical community, offering insights into fenbendazole's multifaceted ...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
